Description
Product Overview / 商品概要
Laennec Injection 2mL x 50 vials (ラエンネック)
Generic: Water-soluble substances of placental enzyme hydrolysate (human placenta-derived component) / 胎盤酵素分解物の水溶性物質(ヒト胎盤由来成分)
Therapeutic Category: Protein/Amino Acid Preparation; Hepatic Function Improver; Hepatic Reserve Activator / たん白アミノ酸製剤・肝機能改善剤・肝予備能賦活剤
Manufactured by: Japan Biological Products Co., Ltd. / 株式会社日本生物製剤
Composition & Specification / 組成・規格
Active Ingredient: Water-soluble substances of placental enzyme hydrolysate (human placenta-derived component) 112mg per 1 vial (2mL) / 1管2mL中 胎盤酵素分解物の水溶性物質(ヒト胎盤由来成分)112mg
Additives: pH adjuster q.s. Pepsin (porcine, gastric mucosa) and lactose (bovine, milk) are used during the manufacturing process. / pH調整剤 適量。製造工程中でペプシン(ブタ、胃粘膜)、乳糖(ウシ、乳)を使用
Appearance: Clear light yellowish-brown to yellowish-brown solution with a characteristic odor; pH 5.5–6.5; osmotic pressure ratio approximately 1 (relative to physiological saline)
外観: 淡黄褐色~黄褐色の澄明な液、特異なにおいがある、pH 5.5〜6.5、浸透圧比 約1(生理食塩水に対する比)
Indications / 効能効果
EN: Improvement of hepatic function in chronic liver disease
JA: 慢性肝疾患における肝機能の改善
Dosage and Administration / 用法用量
EN: The usual adult dose is 2mL administered subcutaneously or intramuscularly once daily. Depending on symptoms, the dose may be increased to 2–3 times daily.
JA: 通常成人1日1回2mLを皮下又は筋肉内に注射する。症状により1日2〜3回注射することができる。
Contraindications / 禁忌
EN: Patients with a history of hypersensitivity to this product
JA: 本剤に対し過敏症の既往歴のある患者
Regulatory Information / 規制情報
Approval No.: 14900AMZ00229
Sales Started: July 1974 / 1974年7月
Classification Code: 873259
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年
Packaging / 包装
Main Package (for sale): 2mL x 50 vials / 1管2mL×50管
Other Available Packages (by special order): 2mL x 50 vials, 2mL x 10 vials
Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.




Reviews
There are no reviews yet.